IRIDEX CORP Deferred Revenue Recognized
IRIDEX CORP (IRIX) reported Deferred Revenue Recognized of $1.02 million for the 6-month period ending 2021-07-03, per its 10-Q filed 2021-08-12.
Discontinued › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2021-08-12
- IRIDEX CORP contract with customer, liability, revenue recognized for the quarter ending 2021-04-03 was $427.00K, a 20.19% decline year-over-year.
- IRIDEX CORP contract with customer, liability, revenue recognized for the quarter ending 2020-03-28 was $535.00K, a 0.56% increase year-over-year.
- IRIDEX CORP contract with customer, liability, revenue recognized for the quarter ending 2019-03-30 was $532.00K, a 6.83% increase year-over-year.
- IRIDEX CORP contract with customer, liability, revenue recognized for the quarter ending 2018-03-31 was $498.00K.
- IRIDEX CORP contract with customer, liability, revenue recognized for fiscal 2019 was $2.58M, a 13.16% increase from fiscal 2018.
- IRIDEX CORP contract with customer, liability, revenue recognized for fiscal 2018 was $2.28M, a 73.44% increase from fiscal 2017.
- IRIDEX CORP contract with customer, liability, revenue recognized for fiscal 2017 was $1.31M.
| Period end | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 3 month as first filed | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 6 month as first filed | Contract with Customer, Liability, Revenue Recognized 9 month | Contract with Customer, Liability, Revenue Recognized 12 month |
|---|---|---|---|---|---|---|
| 2021-07-03 | $1.02M 10-Q · filed 2021-08-12 | |||||
| 2021-04-03 | $427.00K 10-Q · filed 2021-05-12 | |||||
| 2020-09-26 | $1.52M 10-Q · filed 2020-11-10 | |||||
| 2020-06-27 | $1.02M 10-Q · filed 2020-08-07 | |||||
| 2020-03-28 | $535.00K 10-Q · filed 2021-05-12 | |||||
| 2019-12-28 | $2.58M 10-K · filed 2020-03-13 | |||||
| 2019-09-28 | $1.91M 10-Q · filed 2019-11-08 | |||||
| 2019-06-29 | $1.23M 10-Q · filed 2020-08-07 | $1.23M 10-Q · filed 2019-08-07 | ||||
| 2019-03-30 | $532.00K 10-Q · filed 2020-05-12 | $516.00K 10-Q · filed 2019-05-07 | ||||
| 2018-12-29 | $2.28M 10-K · filed 2020-03-13 | |||||
| 2018-09-29 | $1.73M 10-Q · filed 2019-11-08 | |||||
| 2018-06-30 | $993.00K 10-Q · filed 2019-08-07 | |||||
| 2018-03-31 | $498.00K 10-Q · filed 2019-05-07 | |||||
| 2017-12-30 | $1.31M 10-K · filed 2019-03-29 | |||||
| 2017-09-30 | $961.00K 10-Q · filed 2018-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |